Hiroaki Inagaki

This inventor holds 12 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Arqule, Inc., Daiichi Sankyo Company, Limited, Daiichi Pharmaceutical Co., Ltd.. Active years: 2009-2022.

USPTO Granted Patents = 12 (Patent Applications = 6)

% Patents Active = 58.3

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 16(Granted Patents)

Location History:

Tokyo, JP (2013 - 2021)
Edogawa-ku, JP (2009 - 2022)

Company Filing History:

Daiichi Sankyo Company, Limited

patents

2 out of 200

Daiichi Pharmaceutical Co., Ltd.

patents

4. 1 out of 1

Opna Immuno-Oncology Sa

patent

Years Active: 2009-2022

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11446287 - Compounds and methods for EP300 or CBP modulation and indications therefor (2022-09-20),

2. 11020400 - Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof (2021-06-01),

3. 11020398 - Amino-pyrrolopyrimidinone compounds and methods of use thereof (2021-06-01),

4. 10933065 - Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof (2021-03-02),

5. 10851092 - Pyridine compound (2020-12-01),

6. 10245263 - Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof (2019-04-02),

7. 9630968 - Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof (2017-04-25),

8. 8952010 - Amino group-containing pyrrolidinone derivative (2015-02-10),

9. 8618094 - Fused substituted aminopyrrolidine derivative (2013-12-31),

10. 8476429 - Tri-, tetra-substituted-3-aminopyrrolidine derivative (2013-07-02),

11. 8211910 - Tri-, tetra-substituted-3-aminopyrrolidine derivative (2012-07-03),

12. 7563805 - Tri-, tetra-substituted-3-aminopyrrolidine derivative (2009-07-21),

Title: Hiroaki Inagaki: Pioneering Innovator in the World of Inventions

Introduction: Hiroaki Inagaki, a visionary inventor hailing from Tokyo, JP, has made a significant impact on the realm of innovation through his unwavering commitment to excellence and groundbreaking inventions.

Latest Patents: With an impressive portfolio of 12 patents, Hiroaki's latest patents include revolutionary compounds and methods for EP300 or CBP modulation, as well as amino-pyrrolopyrimidinone compounds aimed at modulating the activity of BTK for treating various diseases.

Career Highlights: Throughout his illustrious career, Hiroaki has lent his expertise to renowned companies such as Arqule, Inc. and Daiichi Sankyo Company, Limited, where he has spearheaded cutting-edge research and development initiatives.

Collaborations: Hiroaki has collaborated closely with esteemed colleagues like Kiyoshi Nakayama and Jean-Marc Lapierre, fostering a collaborative environment that has led to groundbreaking advancements in the field of pharmaceuticals.

Conclusion: Hiroaki Inagaki's passion for innovation and his remarkable contributions to the world of inventions serve as a beacon of inspiration for future generations, setting a high standard for creativity and ingenuity in the pursuit of scientific advancements.